Amanote Research

Amanote Research

    RegisterSign In

Pancreatic Cancer Is ‘Always Non-Resectable’

Digestive Diseases - Switzerland
doi 10.1159/000103904
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineGastroenterology
Date

January 1, 2007

Authors
Klaus MönkemüllerLucia C. FryPeter Malfertheiner
Publisher

S. Karger AG


Related search

Management of Borderline Resectable Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Clinicodemographic Aspect of Resectable Pancreatic Cancer and Prognostic Factors for Resectable Cancer

World Journal of Surgical Oncology
SurgeryOncology
2012English

Pancreatic Mass Is Not Always Adenocarcinoma

Kansas Journal of Medicine
2015English

Resectable Pancreatic Cancer Needs Surgery, Then Chemotherapy

BMJ
2004English

Improving Outcomes in Patients With Resectable Pancreatic Cancer

British Journal of Surgery
Surgery
2017English

Cutting‐edge Strategies for Borderline Resectable Pancreatic Cancer

Annals of Gastroenterological Surgery
2019English

Preoperative Predictors for Early Recurrence of Resectable Pancreatic Cancer

World Journal of Surgical Oncology
SurgeryOncology
2017English

Preoperative Nomogram to Predict Survival for Patients With Resectable and Borderline Resectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2017English

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Clinical Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy